3. Ballard K, Shuman V. Hidradenitis suppurativa. StatPearls. 2019. Tersedia pada: https://www.ncbi.nlm.nih.gov/books/NBK534867/
5. Saunte DML, Jemec GBE. Hidradenitis suppurativa: Advances in diagnosis and treatment. JAMA - J Am Med Assoc. 2017;318(20):2019–32.
13. Jovanovic M. Hidradenitis Suppurativa. Medscape. 2019. Tersedia pada: https://emedicine.medscape.com/article/1073117-overview
16. Scheinfeld N. Treatment of hidradenitis suppurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pregabalin, duloxetine, and venlafaxine. Dermatol Online J. 2013;19(11):20616.
17. Smith S, Cains G, Penas P, Foley P, Frew J, Gebauer K, et al. Management of hidradenitis suppurativa: an Australasian consensus statement. New Zealand Dermatological Society. 2018.
18. Van Der Zee HH, Prens EP, Boer J. Deroofing: A tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol. 2010;63(3):475–80.
19. Blok JL, Spoo JR, Leeman FWJ, Jonkman MF, Horváth B. Skin-tissue-sparing excision with electrosurgical peeling (STEEP): A surgical treatment option for severe hidradenitis suppurativa Hurley stage II/III. J Eur Acad Dermatology Venereol. 2015;29(2):379–82.
22. Magalhães, R. F., Rivitti-Machado, M. C., Duarte, G. V., et al. Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology. Anais Brasileiros de Dermatologia, 2019. 94(2 suppl 1), 7–19. doi:10.1590/abd1806-4841.20198607